Review/Discussion

NEW!  Huang H, Weintraub A, Fang H, Nord CE.  Antimicrobial resistance in Clostridium difficule.  Int J Antimicrob Agents 2009 Oct 12 [Epub ahead of print].

Chambers HF, DeLeo FR.  Waves of resistance: Staphylococcus aureus in the antibiotic era.  Nature Reviews Microbiology 2009;7:629-641.

Focus on Antibiotic Stewardship.  International Journal of Antimicrobial Agents; Volume 34, Supplement 3, Pages i, S1-S19 (August 2009).

     Gould IM. Antibiotic resistance: the perfect storm. International Journal of Antimicrobial Agents 2009;34:S2-S5.

     Wilcox MH. The tide of antimicrobial resistance and selection. International Journal of Antimicrobial Agents 2009;34:S6-S10.

     Liebowitz LD. MRSA burden and interventions. International Journal of Antimicrobial Agents 2009;34:S11-S13.

     García MS. Early antibiotic treatment failure. International Journal of Antimicrobial Agents 2009;34:S14-S19.

Johnsen PJ, Townsend JP, Bøhn T, et al. Factors Affecting the Reversal of Antimicrobial Drug Resistance. Lancet Infect Dis 2009;9(6):357-64.

Johnston BL, Bryce E. Hospital Infection Control Strategies for Vancomycin-resistant Enterococcus, Methicillin-Resistant Staphylococcus aureus and Clostridium difficile. CMAJ 2009;180(6):627-31.

Kirkland KB.  Bacterial colonization: Can we live with it?  Clinical Infectious Diseases 2009;48:1382-1384.

Low DE.  Fluoroquinolones for treatment of community-acquired pneumonia and tuberculosis: putting the risk of resistance into perspective.  Clinical Infectious Diseases 2009;48:1361-1363.

Powers JH.  Risk perception and inappropriate antimicrobial use: yes, it can hurt.  Clinical Infectious Diseases 2009;48:1350-1353.

Arias CA, Murray BE.  Antibiotic-resistant bugs in the 21st Century - A clinical super-challenge.  N Engl J Med 2009;360:439-443.

Antimicrobial Resistance: Problem Pathogens and Clinical Countermeasures.  Edited by Robert C. Owens, Jr., and Ebbing Lautenbach.  New York: Informa Healthcare, 2008.  ISBN 978-0-8247-2941-7.

Larson EL, Cohen B, Ross B, Behta M.  Isolation Precautions for Methicillin-Resistant Staphylococcus aureus: Electronic Surveillance to Monitor Adherence.  Am J Crit Care first published on February 20, 2009 as doi:10.4037/ajcc2009467.

Mulvey MR, Simor AE.  Antimicrobial resistance in hospitals: how concerned should we be?  CMAJ 2009;180(4):408-15.

Nicolle L, Conly JM, MacDonald N.  Embracing ecology to limit antimicrobial resistance.  CMAJ 2009;180(4):371-2. [in press]

Shorr AF.  Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit.  Crit Care Med 2009 [Epub ahead of print]

Domonoske C, Severson K.  Antimicrobial use and bacterial resistance in neonatal patients.  Crit Care Nurs Clin North Am. 2009;21(1):87-95, vii

Vega CP.  Efforts to Reduce Unnecessary Antibiotic Prescribing: Are They Worth It?  A Best Evidence Review.  Medscape Family Medicine 2009.

Ranji SR, Steinman MA, Shojania KG, Gonzales R.  Interventions to reduce unnecessary antibiotic prescribing: a systematic review and quantitative analysis.  Med Care 2008;48:847-862.

Dohmen PM.  Antibiotic resistance in common pathogens reinforces the need to minimise surgical site infections.  J Hosp Infection 2008;70(Suppl 2):15-20.

Vrtis M.  Is Your Patient Taking the Right Antimicrobial?  American Journal of Nursing 2008;108(6):49-55.

Hart AM, Patti A, Noggle B, Haller-Stevenson E, and Hines LB.  Acute Respiratory Infections and Antimicrobial Resistance.  American Journal of Nursing 2008;108(6):49-55.

Meier BM, Stone PW, and Gebbie KM.  Public health law for the collection and reporting of health care-associated infections.  American Journal of Infection Control 2008;36(8):537-551.

Carson R, Larson E, Levy SB, Marshall BM, Aiello AE.  Use of antibacterial products containing quarternary ammonium compounds and drug resistance in the community.  J Antimicrob Chemotherap 2008; Aug 11. [Epub ahead of print]

Cohen AL, Calfee D, Fridkin SK, et al.  Recommendations for Metrics for Multidrug-Resistant Organisms in Healthcare Settings: SHEA/HICPAC Position Paper.  Infection Control and Hospital Epidemiology 2008; 29(10): 901-913.

Klevens RM, Edwards JR, Gaynes RP.  The impact of antimicrobial-resistant, health care-associated infections on mortality in the United States.  Clinical Infectious Diseases 2008;47:927-930.

Costa SF.  Impact of antimicrobial resistance on the treatment and outcome of patients with sepsis.  Shock 2008; [Epub ahead of print]

Hawkey PM.  The growing burden of antimicrobial resistance.  J Antimicrob Chemother 2008;62 Suppl 1:i1-9. 

Linder JA.  Antibiotics for Treatment of Acute Respiratory Tract Infections: Decreasing Benefit, Increasing Risk, and the Irrelevance of Antimicrobial Resistance.  Clinical Infectious Diseases 2008;47:744–746.

Sipahi OR.  Economics of antibiotic resistance.  Expert Rev Anti Infect Ther 2008;6(4):523-39.

AVAILABLE FOR CME CREDIT!  Methicillin-Resistant Staphylococcus aureus: An Evolving Clinical Challenge.  Clinical Infectious Disease 2008;46(Suppl 5): S339-S398.  View the CME Information and the CME Questions.

Hirsch MS, Gunthard HF, Schapiro JM, Brun-Vezinet F, Clotet B, Hammer SM, Johnson VA, Kuritzkes DR, Mellors JW, Pillay D, Yeni PG, Jacobsen DM, Richman DD.  Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society - USA Panel.  Clinical Infectious Diseases 2008;47:266-285.

Clements A, Halton K, Graves N, Pettitt A, Morton A, Looke D, Whitby M.  Overcrowding and understaffing in modern health-care systems: key determinants in meticillin-resistant Staphylococcus aureus transmission.  Lancet Infect Dis. 2008;8:427-34.

Santos RP, Mayo TW, Siegel JD.  Healthcare Epidemiology: Active Surveillance Cultures and Contact Precautions for Control of Multidrug-Resistant Organisms: Ethical Considerations.  Clinical Infectious Diseases 2008;47:110-116.

Davies J.  Resistance redux. Infectious diseases, antibiotic resistance and the future of mankind.  EMBO reports 2008; 9(S1):S18-S21.

John JF, Harvin AM.  History and evolution of antibiotic resistance in coagulase-negative staphylococci: Susceptibility profiles of new anti-staphylococcal agents.  Ther Clin Risk Manag. 2007;3(6):1143-52.

Lewis K.  Multidrug tolerance of biofilms and persister cells.  Curr Top Microbiol Immunol 2008;322:107-31.

Anderson GG and O'Toole GA.  Innate and induced resistance mechanisms of bacterial biofilms.  Curr Top Microbiol Immunol 2008;322:85-105.

Tong  SYC, McDonald MI, Holt DC, Currie BJ.  Global Implications of the Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus in Indigenous Populations.  Clinical Infectious Diseases 2008; 46(12):1871-1878.

Karchmer AW and Bayer AS.  Introduction: Methicillin-Resistant Staphylococcus aureus: An Evolving Clinical Challenge.  Clinical Infectious Diseases 2008;46(S5):S342-3.

Boucher HW and Corey GR.  Epidemiology of Methicillin-Resistant Staphylococcus aureus. Clinical Infectious Diseases 2008;46(S5):S344-9.

Gordon RJ and Lowy FD.  Pathogenesis of Methicillin-Resistant Staphylococcus aureus Infection.  Clinical Infectious Diseases 2008;46(S5):S350-9.

Sakoulas G and Moellering RC Jr.  Increasing Antibiotic Resistance among Methicillin-Resistant Staphylococcus aureus Strains. Clinical Infectious Diseases 2008;46(S5):S360-7.

Stryjewski ME and Chambers HF.  Skin and Soft-Tissue Infections Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus. Clinical Infectious Diseases 2008;46(S5):S368-77.

Rubinstein E, Kollef MH, and Nathwani D.  Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus.  Clinical Infectious Diseases 2008;46(S5):S378-85.

Cosgrove SE and Fowler VG Jr.  Management of Methicillin-Resistant Staphylococcus aureus Bacteremia.   Clinical Infectious Diseases 2008;46(S5):S386-93.

Chastre J.  Evolving problems with resistant pathogens.  Clin Microbiol Infect 2008;14(Suppl 3):3-14.

Maragakis LL, Perl TM.  Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.  Clin Infect Dis 2008;46:1254-63

Siegel RE.  Emerging gram-negative antibiotic resistance: daunting challenges, declining sensitivities, and dire consequences.  Respir Care 2008; 53(4):471-9. 

Rice LB.  Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE.  The Journal of Infectious Diseases 2008; 197(8): 1079-1081.

Friedman CR and Whitney CG.  It's Time for a Change in Practice: Reducing Antibiotic Use Can Alter Antibiotic Resistance.  The Journal of Infectious Diseases 2008; 197(8): 1082-1083.

Peters NK, Dixon DM, Holland SM, and Fauci AS.  The Research Agenda of the National Institute of Allergy and Infectious Diseases for Antimicrobial Resistance.  The Journal of Infectious Diseases 2008; 197(8): 1087-1093.

Boyce JM. Community-associated Methicillin-Resistant Staphylococcus aureus as a cause of health care-associated infection.  Clinical Infectious Diseases 2008;46:795-798.

Uckay I, Sax H, Harbarth S, Bernard L, Pittet D.  Multi-resistant infections in repatriated patients after natural disasters: lessons learned from the 2004 tsunami for hospital infection control.  Journal of Hospital Infection 2008;68:1-8.

Griffin FA.  5 Million Lives Campaign.  Reducing methicillin-resistant Staphylococcus aureus (MRSA) infections.  Joint Commission Journal on Quality and Patient Safety 2007;33:726-31.

Waller S, Jim Beattie T.  Does antimicrobial prophylaxis affect recurrent urinary tract infections and bacterial resistance in children?  Nature Clinical Practice Urology 2008 Feb 19 [Epub ahead of print].

Bellissimo-Rodrigues F.  Antimicrobial drug use and antibiotic-resistant bacteria.  Emerg Infect Dis. 2008 Jan;14(1):187-8.

Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC.  Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006.  Clin Infect Dis. 2008 Mar 1;46(5):668-74.

Okeke IN, Aboderin OA, Byarugaba DK, Ojo KK, Opintan JA.  Growing problem of multidrug-resistant enteric pathogens in Africa.  Emerging Infectious Diseases 2007;13(11):1640-6.

Gorwitz RJ. A review of community-associated Methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatric Infectious Disease Journal 2008;27:1-7.

Kanafani ZA, Perfect JR.  Resistance to antifungal agents: Mechanisms and clinical impact.  Clinical Infectious Diseases 2008;46:120-128.

Gorwitz RJ.  A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.  Pediatr Infect Dis J 2008;27:1-7.

Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards Jr. J.  The epidemic of antibiotic-resistant infections: A call to action for the medical community from the Infectious Diseases Society of America.  Clinical Infectious Diseases 2008;46:155-164.

Bush-Knapp ME, Brinsley-Rainisch KJ, Lawton-Ciccarone RM, Sinkowitz-Cochran RL, Dressler DD, Budnitz T, Williams MV.  Spreading the word, not the infection: Reaching hospitalists about the prevention of antimicrobial resistance.  Am J Infect Control 2007;35:656-661.

Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999–2005. Emerg Infect Dis [serial on the Internet]. 2007 Dec.

Moellering RC, Jr., Graybill JR, McGowan JE, Jr., Corey L. Supplement: Antimicrobial resistance prevention initiative--an update: Proceedings of an expert panel on resistance. American Journal of Infection Control 2007;35:21A-S26.

Gross PA, Patel B.  Reducing antibiotic overuse: a call for a national performance measure for not treating asymptomatic bacteriuria.  Clin Infect Dis. 2007 Nov 15;45(10):1335-7.

Humphreys H.  Understanding why methicillin-resistant staphylococcus aureus control measures are successful in different countries.  Infect Control Hosp Epidemiol 2007;28:1418-1419.

DANMAP. Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, foods and humans in Denmark. 2006. Danish Veterinary and Food Administration; Danish Medicines Agency; National Veterinary Institute and National Food Institute, Technical University of Denmark. 

New York City Department of Health and Mental Hygiene. Surveillance for vancomycin resistance in Staphylococcus aureus. 2007 Alert # 31.

Foley SL, Lynne AM. Food animal-associated Salmonella challenges: Pathogenicity and antimicrobial resistance. J Anim Sci. 2007 Sep 18; [Epub ahead of print].

Verma C, Seebah S, Low SM, Zhou L, Liu SP, Li, J, Beuerman RW. Defensins: Antimicrobial peptides for therapeutic development. Biotechnol J. 2007 Sep 20; [Epub ahead of print].

Shardell M, Harris AD, El-Kamary SS, Furuno JP, Miller RR, Perencevich EN. Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin Infect Dis. 2007 Oct 1; 45(7): 901-907.

Neofytos D, Kuhn B, Shen S, Zhu XH, Jungkind D, Flomenberg P. Emergence of staphylococcal cassette chromosome mec type IV methicillin-resistant Staphylococcus aureus as a cause of ventilator-associated pneumonia. Infect Control Hosp Epidemiol. 2007 Oct; 28(10): 1206-1209.

Conterno LO, Shymanski J, Ramotar K, Toye B, van Walraven C, Coyle D, Roth R. Real-time polymerase chain reaction detection of methicillin-resistant Staphylococcus aureus: Impact on nosocomial transmission and costs. Infect Control Hosp Epidemiol. 2007 Oct; 28(10):1134-1141.

Clemmitt M. Fighting Superbugs. The CQ Researcher. 2007 Aug 24; 17: 673-696.  (Reprinted with permission from CQ Press. View other articles in this publication at: CQ Researcher.) 

Ghanem G, Hachem R, Jian Y, Chemaly RF, Raad I. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacterium in cancer patients. Infect Control Hosp Epidemiol. 2007 Sept; 28(9): 1054-1059.

Hoste EAJ, Vandijck DM, Vanholder RC, De Waele JJ, Lameire NH, Claus S, et al. Health implications of antimicrobial resistance for patients with acute kidney injury and bloodstream infection. Infect Control Hosp Epidemiol. 2007 Sept; 28(9): 1107-1110.

Plantenga MS, Strausbaugh LJ, Infectious Diseases Society of America Emerging Infections Network. Use of decolonization to prevent staphylococcal infections in various healthcare settings: Results of an Emerging Infections Network survey. Infect Control Hosp Epidemiol. 2007 Sept; 28(9): 1111-1113.

Kader AA, Kumar A, Kamath KA. Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals. Infect Control Hosp Epidemiol. 2007 Sept; 28(9): 1114-1116.

Wenzel RP, Bearman G, Edmond MB. Community-acquired methicillin-resistant Staphylococcus aureus (MRSA): New issues for infection control. Intern J Antim Agents. 2007 Sept; 30(3): 210-212.

Perlin DS. Resistance to echinocandin-class antifungal drugs. Drug Resis Updates. 2007; 10: 121-130.

September 1st Supplement of Clinical Infectious Diseases is devoted to antimicrobial resistance.

September 15th Supplement of Clinical Infectious Diseases is devoted to antimicrobial resistance.

Li J, Nation RL, Owen RJ, Wong S, Spelman D, Franklin C. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: Promising therapeutic options for treatment of infection and colistin-resistant strains. Clin Infect Dis. 2007 Sept 1; 45(5): 594-598.

Boucher HW & Sakoulas G. Perspectives on daptomycin resistance, with emphasis on resistance in Staphylococcus aureus. Clin Infect Dis. 2007 Sept 1; 45(5): 601-608.

Elixhauser A & Steiner C. Infections with methicillin-resistant Staphylococcus aureus (MRSA) in U.S. hospitals, 1993-2005. Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality. 2007 Jul; Statistical Brief #35.

Moellering RC Jr, Graybill JR, McGowan JE Jr, Corey L. Antimicrobial resistance prevention initiative--an update: Proceedings of an expert panel on resistance. Am J Med. 2007 Jul; 120(7): S4-25.

Hotz RL. Evolution at work: Watching bacteria grow drug resistant. Science Journal of the The Wall Street Journal. 2007 June 8; B1.

Deresinski S. Vancomycin: Does it still have a role as an antistaphylococcal agent? Expert Rev Anti Infect Ther. 2007 Jun; 5(3):393-401.

Gillespie EE, Boer FJ, Stuart RL, Buist MD, Wilson JM. A sustained reduction in the transmission of methicillin resistant Staphylococcus aureus in an intensive care unit. Crit Care Resusc. 2007 Jun; 9(2):161-5.

Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstein E, Hoban DJ, Noreddin AM, Karlowsky JA. Comparative review of the carbapenems.  Drugs. 2007; 67(7):1027-52.

Goldstein FW. Combating resistance in a challenging, changing environment. Clin Mircoiol Infect. 2007 Jun; 13 Suppl 2:2-6.

Rossolini GM. Redesigning beta-lactams to combat resistance: Summary and conclusions. Clin Microbiol Infect. 2001 Jun; 13 Suppl 2:30-3.

Handsfield HH. Methicillin-resistant Staphylococcus aureus infections in sex partners: What is a sexually transmitted disease? (Letter to the editor.) Clin Infect Dis. 2007 June 15; 44(12): 1664.

Cook HA, Furuya EY, Larson E, Vasquez G, Lowy FD. Reply to Handsfield. Clin Infect Dis. 2007 June 15; 44(12): 1664.

Mohr JF, Murray BE. Point: Vancomycin is not obsolete for treatment of infection caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2007 June 15; 44(12): 1536-42.

Deresinkski S. Counterpoint: Vancomycin and Staphylococcus aureus - an antibiotic enters obsolescence. Clin Infect Dis. 2007 June 15; 44(12): 1543-8.

Haar CH, Cobelens FGJ, Kalisvaart NA, van der Have JJ, van Gerven PJHJ, van Soolingen D. Tuberculosis drug resistance and HIV infection, the Netherlands. Emerg Infect Dis [serial on the Internet]. 2007 May. Available from http://www.cdc.gov/EID/content/13/5/776.htm.

Poirel L, Villa L, Bertini A, Pitout JD, Nordmann P, Carattoli A. Expanded-spectrum β-lactamase and plasmid-mediated quinolone Resistance. Emerg Infect Dis [serial on the Internet]. 2007 May. Available from http://www.cdc.gov/EID/content/13/5/803.htm.

Mwangi MM, Shang WW, Zhou Y, Sieradzki K, de Lencastre H, Richardson P, Bruce D, Rubin E, Myers E, Siggia ED, Tomasz A. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proceed Nat Acad Sci. 2007 May; 104(22):9451-9456.

Cookson B. Hypervirulent strains of Clostridium difficile. Postgrad Med J. 2007 May; 83(979):291-5. 

Arias DC. Tuberculosis rates level off, but drug resistance a concern: More research, funding called for. The Nation's Health (Medscape). 2007; 37(4).

Wright GD, Sutherland AD. New strategies for combating multidrug-resistant bacteria. Trends Mol Med. 2007 May 8; [epub ahead of print].

Delgado M, Neto I, Correia JHD, Pomba Constanca. Antimicrobial resistance and evaluation of susceptibility testing among pathogenic enterococci isolated from dogs and cats. Int J Antimicrob Agents. 2007 May 15 [epub ahead of print].

Kawasaki K, China K, Nishijima M. Release of lipopolysaccharide deacylase PagL from latency compensates from lack of lipopolysaccharide aminoarabinose modification-dependent resistance in antimicrobial peptide polymyxin B in Salmonella enterica. J Bacteriol. 2007 May 4; [Epub ahead of print].

Bubacz MR. Community-acquired methicillin-resistant Staphylococcus aureus: An ever-emerging epidemic. AAOHN J. 2007 May; 55(5):193-4.

Veerman EC, Valentijn-Benz M, Nazmi K, Ruissen AL, Walgreen-Weterings E, van Marle J, Doust AB, van T Hof W, Bolscher JG, Nieuw Amerongen AV. Energy depletion protects Candida albicans against antimicrobial peptides by rigidifying its cell membrane. J Biol Chem. 2007 May 7 [Epub ahead of print].

Hsu YM, Shieh HK, Chen WH, Sun TY, Shiang JH. Antimicrobial susceptibility, plasmid profiles, and haemocin activities of Avibacterium paragallinarum strains. Vet Microbiol. 2007 Apr 19; [Epub ahead of print].

Toleman MA, Bennett PM, Bennett DMC, Ronald N. Jones RN, Walsh TR. Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes. Emerg Infect Dis [serial on the Internet]. 2007 Apr. Available from http://www.cdc.gov/EID/content/13/4/559.htm.

Saye DE. Recurring and antimicrobial-resistant infections: Considering the potential role of biofilms in clinical practice. Ostomy Wound Manage. 2007 Apr; 53(4):46-62.

Tristan A, Bes M, Meugnier H, Lina G, Bozdogan B, Courvalin P, et al. Global distribution of Panton-Valentine leukocidin–positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis [serial on the Internet]. 2007 Apr. Available from http://www.cdc.gov/EID/content/13/4/594.htm.

Falagas ME, Bliziotis IA, Michalopoulos A, Sermaides G, Papaioannou VE, Nikita D, Choulis N. Effect of a policy for restriction of selected classes of antibiotics on antimicrobial drug cost and resistance. J Chemother 2007 Apr; 19(2): 178-84.

Diekema DJ, Edmond MB. Look before you leap: Active surveillance for multidrug-resistant organisms. Clin Infect Dis. 2007 Apr 15; 44(8): 1101-7. 

Robert Wood Johnson Foundation. Incentives essential to ease antibiotic resistance crisis. 2007 Mar. 

Gorwitz RJ. Editorial Commentary: The role of ancillary antimicrobial therapy for treatment of uncomplicated skin infections in the era of community-acquired methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2007 Mar 15; 44:785-787.

Letter to the Editor. The FDA and the evidence on an antibiotic. The Washington Post. 11 Mar 2007. 

Editorial. Resistant bugs. The Washington Post. 11 Mar 2007.

Falagas ME, Bliziotis IA, Fragoulis KN. Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: A systematic review of the evidence from comparative trials. Am J Infect Control. 2007 Mar; 35(2) 106-14.

Weber SG, Huang SS, Oriola S, Huskins WC, Noskin GA, Harriman K, et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force. Am J Infect Control. 2007 Mar; 35(2) 73-85.

Zell BL, Goldmann DA. Healthcare-associated infection and antimicrobial resistance: Moving beyond description to prevention. Infect Control Hosp Epidemiol. 2007 Mar; 28(3): 261-4.

Rhoten, D. Interdisciplinary research: Trend or transition. The Social Science Research Council.  

Weiss, R. FDA rules override warnings about drug: Cattle antibiotic moves forward despite fears of human risk.  The Washington Post. 4 Mar 2007.

Mejicano GC, Wright M. Web resources for antimicrobial resistance. Clin Infect Dis. 2007 Mar 15; 44:886-887.

Kim S, Hu J, Gautom R, Kim J, Lee B, Boyle DS. CTX-M extended-spectrum β-lactamase, Washington State. Emerg Infect Dis [serial on the Internet]. 2007 Mar. Available from http://www.cdc.gov/EID/content/13/3/513.htm

Drudy D, Kyne L, O'Mahony, R, Fanning S. gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027. Emerg Infect Dis [serial on the Internet]. 2007 Mar. Available from http://www.cdc.gov/EID/content/13/3/504.htm

Kulwichit W, Chatsuwan T, Unhasuta C, Pulsrikarn C, Bangtrakulnonth A, Chongthaleong A. Drug-resistant nontyphoidal Salmonella bacteremia, Thailand. Emerg Infect Dis [serial on the Internet]. 2007 Mar. Available from http://www.cdc.gov/EID/content/13/3/501.htm

Reeves D. The 2005 Garrod Lecture: The changing access of patients to antibiotics - for better or worse? J Antimicrob Chemother. 2007 Feb 8; [Epub ahead of print].

Tega L, Raieta K, Ottaviani D, Russo GL, Blanco G, Carraturo A. Catheter-related bacteremia and multidrug-resistant Acinetobacter lwoffii [letter]. Emerg Infect Dis [serial on the Internet]. 2007 Feb. Available from http://www.cdc.gov/EID/content/13/2/355.htm.

Bizzarro MJ, Gallagher PG. Antibiotic-resistant organisms in the neonatal intensive care unit. Semin Perinatol. 2007 Feb; 31:26-32. 

Falagas ME, Karveli EA. The changing global epidemiology of Acinetobacter baumannii infections: A development with major public health implications. Clin Microbiol Infect. 2007 Feb;13(2):117-9.

Johnson, AP. Drug Evaluation: OPT-80, a narrow-spectrum antibiotic.  Curr Opin Investig Drugs. 2007 Feb; 8(2):168-73.

Su Z, Honek JF. Emerging bacterial enzyme targets. Curr Opin Investig Drugs. 2007 Feb; 8(2): 140-9.

Witte W, Strommenger B, Stanek C, Cuny C. Methicillin-resistant Staphylococcus aureus ST398 in humans and animals, central Europe.  Emerg Infect Dis [serial on the Internet]. Feb 2007. Available from http://www.cdc.gov/EID/content/13/2/255.htm.

Vila J, Marti S, Sanchez-Cespedes J. Porins, efflux pumps and multidrug resistance in Acinobacter baumannii.  J Antimicrob Chemother. 2007 Feb 26; [Epub ahead of print].

Klugman KP. Clinical impact of antibiotic resistance in respiratory tract infections. Intern Jr Antimicr Agents. 2007; 29 (Suppl): S6-S10. 

Talbot TR.  Two Studies Feed the Debate on Active Surveillance for Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci Carriage: To Screen or Not to Screen?.  Journal of Infectious Diseases 2007;195:314-317.

Benton C. Hand hygiene - meeting the JCAHO safety goal: Can compliance with CDC hand hygiene guidelines be improved by a surveillance and educational program? Plast Surg Nurs. 2007 Jan-Mar; 27(1):40-4.

Ocana V, Silva C, Nader-Macias ME. Antibiotic susceptibility of potentially probiotic vaginal lactobacilli. Infect Dis Obstet Gynecol. 2006 Sep; 14(3): 181-82.

Pletz MWR, Fugit RV, McGee L, Glasheen JJ, Keller DL, Welte T, Klugman KP.  Fluoroquinolone-resistant Streptococcus pneumoniae [letter].  Emerg Infect Dis [serial online]. 2006 Sep.
Available from http://www.cdc.gov/ncidod/EID/vol12no09/05-1400.htm  | Download the reprint of this article

Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E.  Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat.  Lancet 2006;368:874-885.

Heuer OE, Hammerum AM, Collignon P, Wegener HC.  Human health hazard from antimicrobial-resistant enterococci in animals and food.  Clin Infect Dis 2006;43:911-916.

Gkrania-Klotsas E, Hershow RC.  Colonization or infection with multidrug-resistant Acinetobacter baumannii may be an independent risk factor for increased mortality.  Clin Infect Dis 2006;43:1224.

October 2006 issue of Infection Control and Hospital Epidemiology devoted to MRSA.

Weber DJ, Rutala WA.  Use of germicides in the home and the healthcare setting: is there a relationship between germicide use and antibiotic resistance?  Infect Control Hosp Epidemiol 2006;27:1107-1119.

Yagupsky P.  Selection of antibiotic-resistant pathogens in the community.  Pediatr Infect Dis J 2006;25:974-976.

Heuer OE, Hammerum AM, Collignon P, Wegener HC.  Human health hazard from antimicrobial-resistant enterococci in animals and food.  Clin Infect Dis 2006;43:911-916.

Falagas M.E. and Kopterides P.  Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature Journal of Hospital Infection, Volume 64, Issue 1, September 2006, Pages 7-15.

Henderson DK. Managing methicillin-resistant staphylococci: A paradigm for preventing nosocomial transmission of resistant organisms American Journal of Infection Control, Volume 34, Issue 5, Supplement 1, June 2006, Pages S46-S54.

Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat.  The Lancet, Volume 368, Issue 9538, 2 September 2006-8 September 2006, Pages 874-885.

Paterson DL.  Serious infections in the intensive care unit: Pseudomonas aeruginosa and Acinetobacter baumannii.  Clin Infect Dis 2006;43:S41-S42.

Bonomo RA, Szabo D.  Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa.  Clin Infect Dis 2006;43:S49-S56.

Harris AD, McGregor JC, Furuno JP.  What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria?  Clin Infect Dis 2006;43:S57-S61.

Kollef MH.  Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit?  Clin Infect Dis 2006;43:S82-S88.

Rice LB.  Challenges in identifying new antimicrobial agents effective for treatment infections with Acinetobacter baumannii and Pseudomonas aeruginosa.  Clin Infect Dis 2006;43:S100-S105.

Harbarth S, Emonet S.  Navigating the World Wide Web in search of resources on antimicrobial resistance.  Clin Infect Dis 2006;43:72-78.

Tenover FC. Mechanisms of antimicrobial resistance in bacteria American Journal of Infection Control, Volume 34, Issue 5, Supplement 1, June 2006, Pages S3-S10.

Fishman N.  Antimicrobial stewardship.  Am J Med 2006;119(6 Suppl 1):S53-S61; discussion S62-S70.

Grigoryan L, Haaijer-Ruskamp FM, Burgerhof JGM, et al.  Self-medication with Antimicrobial Drugs in Europe.  Emerg Infect Dis [serial online]. 2006 Mar.
Available from http://www.cdc.gov/ncidod/eid/vol12no03/05-0992.htm  |  Download the reprint of this article

Metlay JP, Powers JH, Dudley MN, Christiansen K, Finch RG; on behalf of the Second Colloquium of the International Forum on Antibiotic Resistance.  Antimicrobial Drug Resistance, Regulation and Research.  Emerg Infect Dis [serial online]. 2006 Feb.
Available from http://www.cdc.gov/ncidod/eid/vol12no02/05-0078.htm  |  Download the reprint of this article

Davey P, Brown E, Fenelon L, Finch R, Gould I, Holmes A, et al. Systematic review of antimicrobial drug prescribing in hospitals. Emerg Infect Dis [serial online]. 2006 Feb.
Available from http://www.cdc.gov/ncidod/eid/vol12no02/05-0145.htm  |  Download the reprint of this article

Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies: Volume 4 - Antibiotic Prescribing Behavior (Publication No. 04(06)-0051-4), January 2006.

Alanis AJ.  (2005).  Resistance to Antibiotics: Are We in the Post-Antibiotic Era?  Archives of Medical Research 36:697-705. 

Larson EL, Saiman L, Haas J, Neumann A, Lowy FD, Fatato B, Bakken S, and members of the Executive Committee and Expert Liaisons.  (2005).  Perspectives on antimicrobial resistance: Establishing an interdisciplinary research approach.  American Journal of Infection Control 33:410-418.

Courvalin P.  (2005).  Antimicrobial Drug Resistance: "Prediction is Very Difficult, Especially about the Future." Emerg Infect Dis [serial on the Internet].

Gaynes R, Edwards JR, and the National Nosocomial Infections Surveillance System.  (2005).  Overview of Nosocomial Infections Caused by Gram-Negative Bacilli.  Clinical Infectious Diseases 41:848-854.

Gaynes R, Edwards JR, and the National Nosocomial Infections Surveillance System.  (2005).  Overview of Nosocomial Infections Caused by Gram-Negative Bacilli.  Clinical Infectious Diseases 41:848-854.   PS  |  HTML  |  PDF (155.8k)

Weber JT, Courvalin P. An emptying quiver: antimicrobial drugs and resistance. Emerg Infect Dis [serial online]. 2005 Jun.
Available from http://www.cdc.gov/ncidod/EID/vol11no06/05-0471.htm  |  Download the reprint of this article

Harbarth S, Samore MA. Antimicrobial resistance determinants and future control. Emerg Infect Dis [serial online]. 2005 Jun.
Available from http://www.cdc.gov/ncidod/EID/vol11no06/05-0167.htm  |  Download the reprint of this article

Cummings KC, Rosenberg J, Vugia DJ. Beliefs about appropriate antibacterial therapy, California. Emerg Infect Dis [serial online]. 2005 Jul.
Available from http://www.cdc.gov/ncidod/EID/vol11no07/05-0112.htm  |  Download the reprint of this article

McCarthy J.  (2004).  Tackling the Challenges of Interdisciplinary Bioscience.  Molecular Cell Biology 5:933-937.

Levy S.  Antibacterial household products: cause for concern. Presentation from the 2000 Emerging Infectious Diseases Conference in Atlanta, GA.
Available from http://www.cdc.gov/ncidod/EID/vol7no3_supp/levy.htm

Hawley LA, Fridkin SK, Whitney CG. Drug-resistant Streptococcus pneumoniae and methicillin-resistant Staphylococcus aureus surveillance. Emerg Infect Dis [serial online] 2003 Oct.
Available from http://www.cdc.gov/ncidod/EID/vol9no10/03-0454.htm  |  Download the reprint of this article

Back to Top

Supported by the
National Institute of Nursing Research/National Institutes of Health